Sorafenib as first line treatment for advanced liver cancer-are expiries
Naslov
Sorafenib as first line treatment for advanced liver cancer-are expiries
Identifikator
/unibl/sci/idNaucniRad:25642
Tip
Pronađite slične unoseConference Paper
Datum
Bibliografski citat
Z. Gojković, S. Jungić, I. Rakita, R. Rašeta, G. Marić, M. Vještica, S. Mijatović, S. Dašić, M. Vižin, J. Rožić, Sorafenib as first line treatment for advanced liver cancer-are expiries, This article appears in ESMO 14th World Congres of Gastrointestinal Cancer (SCI lista), 2012
Prezentovano
14th World Congres of Gastrointestinal Cancer
Je dio
This article appears in ESMO 14th World Congres of Gastrointestinal Cancer (SCI lista)
Lista autora
Position: 7177 (36 views)